CN Patent

CN110678464A — 马赛替尼的晶型

Assigned to Sandoz AG · Expires 2020-01-10 · 6y expired

What this patent protects

本发明涉及甲磺酸马赛替尼的多晶型物、其制备方法、包含其的药物组合物及其医学用途。

USPTO Abstract

本发明涉及甲磺酸马赛替尼的多晶型物、其制备方法、包含其的药物组合物及其医学用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN110678464A
Jurisdiction
CN
Classification
—
Expires
2020-01-10
Drug substance claim
No
Drug product claim
No
Assignee
Sandoz AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.